Clinical trials regulatory approval timeliness rate
STO-REC-STATT3CXFBT2 National
98%
United Kingdom · as of 8 Sep 2026
Clinical trials regulatory approval timeliness rate in United Kingdom stood at 98% as of 8 September 2026 (ABPI).
- Publisher
- ABPI
- Authority tier
- T2 National
- Locator
- UK areas of unrealised potential
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Study set-up has improved, with 98 per cent of trials receiving regulatory approval within 60 days, though patient recruitment continues to decline and requires attention across the whole trial journey.
Verbatim extraction verified: The figure 98% is directly attested in the quoted passage (UK areas of unrealised potential).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2
- MLA
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026, https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2.
- Chicago
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026. https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2.
- BibTeX
- @misc{abpi2026clinicala9jzf2, author = {{Association of the British Pharmaceutical Industry}}, title = {Green shoots for UK pharma investment, but delivery will decide whether they take root}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2}, note = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- Association of the British Pharmaceutical Industry · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- Green shoots for UK pharma investment, but delivery will decide whether they take root
- Type
- Press release
- Published
- —
- Locator
- UK areas of unrealised potential
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_T3CXFB2BQRJRCBTF1RHGA9JZF2